| 000 | 01206 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516023944.0 | ||
| 264 | 0 | _c20110713 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1473-6322 | ||
| 024 | 7 |
_a10.1097/ACI.0b013e328344575b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVandenplas, Olivier | |
| 245 | 0 | 0 |
_aReduction of exposure in the management of occupational asthma. _h[electronic resource] |
| 260 |
_bCurrent opinion in allergy and clinical immunology _cApr 2011 |
||
| 300 |
_a75-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAsthma _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOccupational Diseases _xeconomics |
| 650 | 0 | 4 |
_aOccupational Exposure _xadverse effects |
| 650 | 0 | 4 |
_aRespiratory Protective Devices _xstatistics & numerical data |
| 650 | 0 | 4 | _aSocioeconomic Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tCurrent opinion in allergy and clinical immunology _gvol. 11 _gno. 2 _gp. 75-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/ACI.0b013e328344575b _zAvailable from publisher's website |
| 999 |
_c20602932 _d20602932 |
||